Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

ObjectivesTo further understand differentiation and homeostasis of CD8 T cells specific for HIV, Epstein-Barr Virus (EBV) and cytomegalovirus (CMV) during HIV infection, we investigated interleukin-7 receptor alpha (IL-7Ralpha) expression on those virus-specific T cells.MethodsMicroarrays and cytometry analyses were performed on peripheral blood mononuclear cells (PBMC), total and tetramer-binding virus-specific CD8 T cells from 66 HIV-infected patients.ResultsMicroarray analysis revealed reduced levels of IL-7Ralpha and increased levels of perforin with disease progression in total PBMC. This loss of IL-7Ralpha expression was observed on CD8 T cells and was inversely related to perforin expression. The relative expression of both molecules defined three new subsets: IL-7Ralpha(pos)Perforin(neg); IL-7Ralpha(loneg)Perforin(lo); and IL-7Ralpha(loneg)Perforin(hi) corresponding to naive and effector-memory CD8 differentiation, as assessed by CD45RA/CD11a. The IL-7Ralpha expression decreased along the CD8 differentiation pathway defined by CD27 and CD28. In contrast, IL-7Ralpha expression was down-modulated on all the CD8 T cells specific for HIV, EBV and CMV that were almost exclusively IL-7Ralpha(lo/neg)Perforin(lo) and was parallel with the CD27 expression. In addition, this low IL-7Ralpha expression on HIV-specific CD8 T cells was independent of virus load and T-cell activation and remained stable during the first 6 months of antiretroviral therapy despite successful control of HIV replication.ConclusionThe relative expression of IL-7Ralpha, perforin reveals new aspects of virus-specific CD8 T cell differentiation, independently of T-cell activation and virus load. This opens new perspectives for understanding homeostasis of those cells and immune-based therapeutic strategies.

Original publication

DOI

10.1097/01.aids.0000191919.24185.46

Type

Journal article

Journal

AIDS (London, England)

Publication Date

11/2005

Volume

19

Pages

1981 - 1986

Addresses

Laboratoire d'Immunologie Cellulaire, Hôpital Pitié-Salpêtrière, Université Pierre et Marie Curie, Paris, France.

Keywords

Leukocytes, Mononuclear, CD8-Positive T-Lymphocytes, Cells, Cultured, Humans, HIV-1, Cytomegalovirus Infections, Epstein-Barr Virus Infections, HIV Infections, Membrane Glycoproteins, Receptors, Interleukin-7, Antiretroviral Therapy, Highly Active, Oligonucleotide Array Sequence Analysis, Cell Differentiation, Gene Expression, Transcription, Genetic, Pore Forming Cytotoxic Proteins, Perforin, CD28 Antigens, Tumor Necrosis Factor Receptor Superfamily, Member 7